From August 5, 2022 to December 21, 2022, the company has repurchased 1,585,320 shares, representing 0.17% for CNY 200.17 million. With this, the company has completed the repurchase of 1,585,320 shares, representing 0.17% for CNY 200.17 million under the buyback announced on August 6, 2022.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Equities
603392
CNE100004090
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
67.19 CNY | +0.93% | +2.86% | -10.57% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.57% | 11.65B | |
-2.18% | 89.01B | |
-3.68% | 37.79B | |
-14.91% | 31.22B | |
+60.33% | 26.1B | |
-22.72% | 14.25B | |
-8.73% | 12.8B | |
+4.04% | 8.7B | |
-17.19% | 7.45B | |
+82.74% | 7.07B |
- Stock Market
- Equities
- 603392 Stock
- News Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
- Tranche Update on Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.'s Equity Buyback Plan announced on August 6, 2022.